Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Assessment and prediction of glioblastoma therapy response: challenges and opportunities

Brain(2022)10.1093/brain/awac450Source: DataRank Database

Assessment and prediction of glioblastoma therapy response: challenges and opportunities is a research paper published in Brain (2022). On theSindex it has a DataRank of 0. It has been cited 65 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access65 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 6.96)OA: greenTopics (36)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Jing Li ORCID,C. Chad Quarles ORCID,Ekokobe Fonkem ORCID,Erxi Wu ORCID,Dan Qi ORCID

Live enrichment

PubMed:36445396 PMC:PMC10319779 OpenAlex:https://openalex.org/W4310463909

Cancer Research

Grant: 62285-531021-61800

Cancer Research

Grant: 62285-531021-41800

National Institutes of Health

Grant: R01CA158079-01

NCI NIH HHS

Grant: R01 CA158079

William and Ella Owens Medical Research Foundation

Grant: 43502512000

Cancer Research

Grant: 62285-531021-71800

Cancer Research

Grant: 62285-531021-51800

Cancer Prevention Research Institute of Texas

Grant: RR220038

National Institutes of Health

Grant: 5R01CA158079-05

MRI Assessment of Tumor Perfusion, Permeability and Cellularity

Corbett Estate Fund

FWCI

6.96

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

greenLicense: OUP Standard Publication Reuse

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10319779/pdf/awac450.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10319779

journalhttps://doi.org/10.1093/brain/awac450

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36445396

Fields of Study

Glioma Diagnosis and TreatmentRadiomics and Machine Learning in Medical ImagingCell Image Analysis Techniques0301 basic medicine0303 health sciences03 medical and health sciencesGlioblastomaHumansDisease ProgressionBiomarkersMachine LearningClinical Decision Rules

MeSH Terms

Machine LearningClinical Decision RulesGlioblastomaHumansBiomarkersDisease Progression

Keywords

GlioblastomaMedicineMalignancyOncologyBiomarkerPrecision medicineInternal medicineIntensive care medicinePathologyCancer researchMachine LearningTherapy ResponseMultiparametric ImagingLiquid BiomarkerClinical Decision RulesDisease ProgressionHumansBiomarkers

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma

10.6084/m9.figshare.27123922.v1figshare

Additional file 1 of An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma

10.6084/m9.figshare.27123922figshare